PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 116.0
(-0.85%)
IDR 116.0
(-0.85%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 651.43 Billion IDR | 20.1% |
| 2022 | 542.38 Billion IDR | 32.42% |
| 2021 | 409.58 Billion IDR | 21.41% |
| 2020 | 337.36 Billion IDR | -27.17% |
| 2019 | 463.19 Billion IDR | 20.84% |
| 2018 | 383.31 Billion IDR | 33.09% |
| 2017 | 288.01 Billion IDR | 9.66% |
| 2016 | 262.63 Billion IDR | 16.64% |
| 2015 | 225.15 Billion IDR | 46.43% |
| 2014 | 153.76 Billion IDR | 7.19% |
| 2013 | 143.44 Billion IDR | 64.07% |
| 2012 | 87.42 Billion IDR | -2.29% |
| 2011 | 89.47 Billion IDR | 15.13% |
| 2010 | 77.71 Billion IDR | 28.39% |
| 2009 | 60.53 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 803.83 Billion IDR | 6.5% |
| 2024 Q3 | 811.72 Billion IDR | 1.06% |
| 2024 Q1 | 754.78 Billion IDR | 15.86% |
| 2023 FY | 651.43 Billion IDR | 20.1% |
| 2023 Q3 | 687.93 Billion IDR | 11.37% |
| 2023 Q1 | 659.08 Billion IDR | 21.51% |
| 2023 Q4 | 651.43 Billion IDR | -5.31% |
| 2023 Q2 | 617.72 Billion IDR | -6.28% |
| 2022 Q2 | 466.92 Billion IDR | 1.83% |
| 2022 Q3 | 527.6 Billion IDR | 12.99% |
| 2022 FY | 542.38 Billion IDR | 32.42% |
| 2022 Q4 | 542.38 Billion IDR | 2.8% |
| 2022 Q1 | 458.55 Billion IDR | 11.95% |
| 2021 Q2 | 428.05 Billion IDR | -4.16% |
| 2021 Q1 | 446.62 Billion IDR | 32.39% |
| 2021 FY | 409.58 Billion IDR | 21.41% |
| 2021 Q4 | 409.58 Billion IDR | -33.92% |
| 2021 Q3 | 619.82 Billion IDR | 44.8% |
| 2020 FY | 337.36 Billion IDR | -27.17% |
| 2020 Q2 | 595.8 Billion IDR | 20.44% |
| 2020 Q4 | 337.36 Billion IDR | -16.05% |
| 2020 Q1 | 494.69 Billion IDR | 6.8% |
| 2020 Q3 | 401.85 Billion IDR | -32.55% |
| 2019 Q2 | 563.48 Billion IDR | 24.34% |
| 2019 FY | 463.19 Billion IDR | 20.84% |
| 2019 Q4 | 463.19 Billion IDR | -14.76% |
| 2019 Q1 | 453.17 Billion IDR | 18.22% |
| 2019 Q3 | 543.38 Billion IDR | -3.57% |
| 2018 Q2 | 380.4 Billion IDR | 39.7% |
| 2018 FY | 383.31 Billion IDR | 33.09% |
| 2018 Q4 | 383.31 Billion IDR | -9.32% |
| 2018 Q3 | 422.69 Billion IDR | 11.12% |
| 2018 Q1 | 272.3 Billion IDR | -5.45% |
| 2017 Q2 | 256.67 Billion IDR | 2.53% |
| 2017 Q4 | 288.01 Billion IDR | -8.26% |
| 2017 Q3 | 313.94 Billion IDR | 22.31% |
| 2017 FY | 288.01 Billion IDR | 9.66% |
| 2017 Q1 | 250.33 Billion IDR | -4.68% |
| 2016 Q1 | 255.86 Billion IDR | 13.64% |
| 2016 FY | 262.63 Billion IDR | 16.64% |
| 2016 Q2 | 277.4 Billion IDR | 8.42% |
| 2016 Q3 | 348.78 Billion IDR | 25.73% |
| 2016 Q4 | 262.63 Billion IDR | -24.7% |
| 2015 Q3 | 248.06 Billion IDR | 21.71% |
| 2015 Q1 | 146.9 Billion IDR | -4.46% |
| 2015 FY | 225.15 Billion IDR | 46.43% |
| 2015 Q4 | 225.15 Billion IDR | -9.23% |
| 2015 Q2 | 203.81 Billion IDR | 38.74% |
| 2014 Q3 | 152.96 Billion IDR | 19.49% |
| 2014 FY | 153.76 Billion IDR | 7.19% |
| 2014 Q4 | 153.76 Billion IDR | 0.52% |
| 2014 Q1 | 109.52 Billion IDR | -23.64% |
| 2014 Q2 | 128.01 Billion IDR | 16.88% |
| 2013 Q4 | 143.44 Billion IDR | 10.99% |
| 2013 Q1 | 88.89 Billion IDR | 423.31% |
| 2013 Q3 | 129.24 Billion IDR | 26.29% |
| 2013 Q2 | 102.34 Billion IDR | 15.12% |
| 2013 FY | 143.44 Billion IDR | 64.07% |
| 2012 Q4 | -27.49 Billion IDR | 2.9% |
| 2012 Q3 | -28.31 Billion IDR | 0.0% |
| 2012 FY | 87.42 Billion IDR | -2.29% |
| 2011 FY | 89.47 Billion IDR | 15.13% |
| 2010 FY | 77.71 Billion IDR | 28.39% |
| 2009 FY | 60.53 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | -683.1 Billion IDR | 195.364% |
| PT Itama Ranoraya Tbk | 148.83 Billion IDR | -337.7% |
| PT Kimia Farma (Persero) Tbk | 7094.31 Billion IDR | 90.817% |
| PT Soho Global Health Tbk | -668.51 Billion IDR | 197.445% |